HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 38% Share Price Surge Not Quite Adding Up
Apr 11
South Korean (KOSPI) Biotech Industry Analysis
UpdatedApr 16, 2024
DataAggregated Company Financials
Companies115
- 7D-2.8%
- 3M1.7%
- 1Y-2.7%
- YTDn/a
Over the last 7 days, the Biotech industry has dropped 2.8%, driven by a pullback from Celltrion of 4.9%. Meanwhile, Hugel actually outperformed within the industry, gaining 5.8% in the last week. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 41% per annum.
Industry Valuation and Performance
Has the South Korean Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 16 Apr 2024 | ₩78.9t | ₩9.6t | -₩589,100,786,928.00 | 21.9x | -133.9x | 8.2x |
| Thu, 14 Mar 2024 | ₩81.1t | ₩9.7t | -₩529,895,238,747.00 | 57.3x | -153.1x | 8.3x |
| Sat, 10 Feb 2024 | ₩73.3t | ₩9.7t | -₩537,261,689,777.00 | 62.6x | -136.4x | 7.5x |
| Mon, 08 Jan 2024 | ₩68.7t | ₩10.1t | -₩324,278,048,367.00 | 30.1x | -211.8x | 6.8x |
| Wed, 06 Dec 2023 | ₩58.1t | ₩10.1t | -₩309,980,431,097.00 | 28.1x | -187.4x | 5.7x |
| Fri, 03 Nov 2023 | ₩54.0t | ₩10.2t | -₩239,053,318,689.00 | 28.1x | -226x | 5.3x |
| Sun, 01 Oct 2023 | ₩55.5t | ₩10.2t | -₩239,053,318,689.00 | 28.3x | -232.1x | 5.4x |
| Tue, 29 Aug 2023 | ₩56.9t | ₩10.1t | -₩379,278,146,849.00 | 35.4x | -150.1x | 5.6x |
| Thu, 27 Jul 2023 | ₩53.1t | ₩10.3t | -₩151,534,704,579.00 | 24.5x | -350.6x | 5.2x |
| Sat, 24 Jun 2023 | ₩59.4t | ₩10.3t | -₩151,534,704,579.00 | 29.8x | -391.7x | 5.8x |
| Mon, 22 May 2023 | ₩62.6t | ₩11.0t | ₩317.8b | 25.6x | 197.1x | 5.7x |
| Wed, 19 Apr 2023 | ₩64.8t | ₩11.0t | ₩317.9b | 24.7x | 203.8x | 5.9x |
| Fri, 17 Mar 2023 | ₩55.1t | ₩11.3t | ₩956.2b | 22.8x | 57.6x | 4.9x |
| Sun, 12 Feb 2023 | ₩59.7t | ₩11.3t | ₩970.8b | 24.6x | 61.5x | 5.3x |
| Tue, 10 Jan 2023 | ₩60.0t | ₩11.4t | ₩685.0b | 22.9x | 87.6x | 5.3x |
| Thu, 08 Dec 2022 | ₩60.3t | ₩10.8t | ₩197.4b | 22.8x | 305.3x | 5.6x |
| Sat, 05 Nov 2022 | ₩60.5t | ₩10.8t | ₩348.0b | 18.7x | 173.8x | 5.6x |
| Mon, 03 Oct 2022 | ₩57.1t | ₩10.8t | ₩392.8b | 20.1x | 145.3x | 5.3x |
| Wed, 31 Aug 2022 | ₩68.6t | ₩10.8t | ₩560.7b | 25.8x | 122.4x | 6.3x |
| Fri, 29 Jul 2022 | ₩70.9t | ₩10.7t | ₩597.6b | 27.1x | 118.7x | 6.6x |
| Sun, 26 Jun 2022 | ₩63.8t | ₩10.7t | ₩597.6b | 23.1x | 106.8x | 6x |
| Tue, 24 May 2022 | ₩66.7t | ₩10.4t | ₩782.4b | 26.1x | 85.3x | 6.4x |
| Thu, 21 Apr 2022 | ₩70.0t | ₩10.0t | ₩898.1b | 27.5x | 78x | 7x |
| Sat, 19 Mar 2022 | ₩78.5t | ₩9.5t | ₩692.5b | 34x | 113.4x | 8.3x |
| Mon, 14 Feb 2022 | ₩72.4t | ₩9.4t | ₩787.4b | 33.9x | 91.9x | 7.7x |
| Wed, 12 Jan 2022 | ₩88.4t | ₩9.4t | ₩787.4b | 38.5x | 112.2x | 9.4x |
| Fri, 10 Dec 2021 | ₩97.7t | ₩9.4t | ₩780.3b | 41.7x | 125.2x | 10.4x |
| Sun, 07 Nov 2021 | ₩98.7t | ₩9.2t | ₩988.3b | 40.6x | 99.8x | 10.7x |
| Tue, 05 Oct 2021 | ₩107.8t | ₩9.2t | ₩986.0b | 39.6x | 109.3x | 11.7x |
| Thu, 02 Sep 2021 | ₩124.2t | ₩9.3t | ₩909.7b | 47.6x | 136.5x | 13.4x |
| Sat, 31 Jul 2021 | ₩103.8t | ₩9.3t | ₩909.7b | 50x | 114.1x | 11.2x |
| Tue, 04 May 2021 | ₩101.2t | ₩9.0t | ₩979.0b | 41.7x | 103.4x | 11.2x |
Price to Earnings Ratio
103.4x
Current Industry PE
- Investors are optimistic on the South Korean Biotechnology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 7.5x is lower than the industry's current PS ratio of 8.2x.
Past Earnings Growth
- Total earnings for the Biotechnology industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 2.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does South Korean Biotech compare with similar industries?
| KR Market | -1.63% | |
| Healthcare | -1.91% | |
| Biotech | -2.81% | |
| Biotech | -2.81% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A145020 Hugel | ₩205.50k | 5.8% +₩122.2b | 75.5% | PE24.1x | |
| A214450 PharmaResearch | ₩125.90k | 6.2% +₩75.5b | 22.1% | PE16.8x | |
| A206650 EuBiologics | ₩13.90k | 12.1% +₩54.7b | 71.2% | PS7.3x | |
| A304360 S.Biomedics | ₩20.65k | 29.9% +₩54.1b | n/a | PS18x | |
| A256840 BNC Korea | ₩6.76k | 7.3% +₩30.5b | 61.1% | PE17.5x |
